Global Genetic Engineering Drug Market Growth 2024-2030
The report requires updating with new data and is sent in 48 hours after order is placed.
According to our LPI (LP Information) latest study, the global Genetic Engineering Drug market size was valued at US$ million in 2023. With growing demand in downstream market, the Genetic Engineering Drug is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period.
The research report highlights the growth potential of the global Genetic Engineering Drug market. Genetic Engineering Drug are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Genetic Engineering Drug. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Genetic Engineering Drug market.
Genetic Engineering Drug is also called Genetic Engineering or Genetic manipulation, and is the direct manipulation of an organism's genes using the Drug required in biotechnology.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Key Features:
The report on Genetic Engineering Drug market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Genetic Engineering Drug market. It may include historical data, market segmentation by Type (e.g., Monoclonal Antibody, Recombinant Human Erythropoietin), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Genetic Engineering Drug market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Genetic Engineering Drug market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Genetic Engineering Drug industry. This include advancements in Genetic Engineering Drug technology, Genetic Engineering Drug new entrants, Genetic Engineering Drug new investment, and other innovations that are shaping the future of Genetic Engineering Drug.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Genetic Engineering Drug market. It includes factors influencing customer ' purchasing decisions, preferences for Genetic Engineering Drug product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Genetic Engineering Drug market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Genetic Engineering Drug market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Genetic Engineering Drug market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Genetic Engineering Drug industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Genetic Engineering Drug market.
Market Segmentation:
Genetic Engineering Drug market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Segmentation by type
What is the 10-year outlook for the global Genetic Engineering Drug market?
What factors are driving Genetic Engineering Drug market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Genetic Engineering Drug market opportunities vary by end market size?
How does Genetic Engineering Drug break out type, application?
According to our LPI (LP Information) latest study, the global Genetic Engineering Drug market size was valued at US$ million in 2023. With growing demand in downstream market, the Genetic Engineering Drug is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period.
The research report highlights the growth potential of the global Genetic Engineering Drug market. Genetic Engineering Drug are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Genetic Engineering Drug. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Genetic Engineering Drug market.
Genetic Engineering Drug is also called Genetic Engineering or Genetic manipulation, and is the direct manipulation of an organism's genes using the Drug required in biotechnology.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Key Features:
The report on Genetic Engineering Drug market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Genetic Engineering Drug market. It may include historical data, market segmentation by Type (e.g., Monoclonal Antibody, Recombinant Human Erythropoietin), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Genetic Engineering Drug market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Genetic Engineering Drug market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Genetic Engineering Drug industry. This include advancements in Genetic Engineering Drug technology, Genetic Engineering Drug new entrants, Genetic Engineering Drug new investment, and other innovations that are shaping the future of Genetic Engineering Drug.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Genetic Engineering Drug market. It includes factors influencing customer ' purchasing decisions, preferences for Genetic Engineering Drug product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Genetic Engineering Drug market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Genetic Engineering Drug market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Genetic Engineering Drug market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Genetic Engineering Drug industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Genetic Engineering Drug market.
Market Segmentation:
Genetic Engineering Drug market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Segmentation by type
- Monoclonal Antibody
- Recombinant Human Erythropoietin
- Recombinant Human Interferon
- Recombinant Human Growth Hormone
- Recombinant Human Insulin
- Medicine
- Research
- Industrial
- Agriculture
- Other
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Shanghai Lansheng Guojian Pharmaceutical
- Biotech Pharmaceutical
- Anhui Anke Biotechnology
- GeneScience Pharmaceuticals
- Beijing SL Pharmaceutical
- Jiangsu Sihuan Bioengineering
- Shenzhen Neptunus Interlong Bio-Technique
- 3SBio
- Tonghua Dongbao Pharmaceutical
What is the 10-year outlook for the global Genetic Engineering Drug market?
What factors are driving Genetic Engineering Drug market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Genetic Engineering Drug market opportunities vary by end market size?
How does Genetic Engineering Drug break out type, application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Genetic Engineering Drug Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Genetic Engineering Drug by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Genetic Engineering Drug by Country/Region, 2019, 2023 & 2030
2.2 Genetic Engineering Drug Segment by Type
2.2.1 Monoclonal Antibody
2.2.2 Recombinant Human Erythropoietin
2.2.3 Recombinant Human Interferon
2.2.4 Recombinant Human Growth Hormone
2.2.5 Recombinant Human Insulin
2.3 Genetic Engineering Drug Sales by Type
2.3.1 Global Genetic Engineering Drug Sales Market Share by Type (2019-2024)
2.3.2 Global Genetic Engineering Drug Revenue and Market Share by Type (2019-2024)
2.3.3 Global Genetic Engineering Drug Sale Price by Type (2019-2024)
2.4 Genetic Engineering Drug Segment by Application
2.4.1 Medicine
2.4.2 Research
2.4.3 Industrial
2.4.4 Agriculture
2.4.5 Other
2.5 Genetic Engineering Drug Sales by Application
2.5.1 Global Genetic Engineering Drug Sale Market Share by Application (2019-2024)
2.5.2 Global Genetic Engineering Drug Revenue and Market Share by Application (2019-2024)
2.5.3 Global Genetic Engineering Drug Sale Price by Application (2019-2024)
3 GLOBAL GENETIC ENGINEERING DRUG BY COMPANY
3.1 Global Genetic Engineering Drug Breakdown Data by Company
3.1.1 Global Genetic Engineering Drug Annual Sales by Company (2019-2024)
3.1.2 Global Genetic Engineering Drug Sales Market Share by Company (2019-2024)
3.2 Global Genetic Engineering Drug Annual Revenue by Company (2019-2024)
3.2.1 Global Genetic Engineering Drug Revenue by Company (2019-2024)
3.2.2 Global Genetic Engineering Drug Revenue Market Share by Company (2019-2024)
3.3 Global Genetic Engineering Drug Sale Price by Company
3.4 Key Manufacturers Genetic Engineering Drug Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Genetic Engineering Drug Product Location Distribution
3.4.2 Players Genetic Engineering Drug Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR GENETIC ENGINEERING DRUG BY GEOGRAPHIC REGION
4.1 World Historic Genetic Engineering Drug Market Size by Geographic Region (2019-2024)
4.1.1 Global Genetic Engineering Drug Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Genetic Engineering Drug Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Genetic Engineering Drug Market Size by Country/Region (2019-2024)
4.2.1 Global Genetic Engineering Drug Annual Sales by Country/Region (2019-2024)
4.2.2 Global Genetic Engineering Drug Annual Revenue by Country/Region (2019-2024)
4.3 Americas Genetic Engineering Drug Sales Growth
4.4 APAC Genetic Engineering Drug Sales Growth
4.5 Europe Genetic Engineering Drug Sales Growth
4.6 Middle East & Africa Genetic Engineering Drug Sales Growth
5 AMERICAS
5.1 Americas Genetic Engineering Drug Sales by Country
5.1.1 Americas Genetic Engineering Drug Sales by Country (2019-2024)
5.1.2 Americas Genetic Engineering Drug Revenue by Country (2019-2024)
5.2 Americas Genetic Engineering Drug Sales by Type
5.3 Americas Genetic Engineering Drug Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Genetic Engineering Drug Sales by Region
6.1.1 APAC Genetic Engineering Drug Sales by Region (2019-2024)
6.1.2 APAC Genetic Engineering Drug Revenue by Region (2019-2024)
6.2 APAC Genetic Engineering Drug Sales by Type
6.3 APAC Genetic Engineering Drug Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Genetic Engineering Drug by Country
7.1.1 Europe Genetic Engineering Drug Sales by Country (2019-2024)
7.1.2 Europe Genetic Engineering Drug Revenue by Country (2019-2024)
7.2 Europe Genetic Engineering Drug Sales by Type
7.3 Europe Genetic Engineering Drug Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Genetic Engineering Drug by Country
8.1.1 Middle East & Africa Genetic Engineering Drug Sales by Country (2019-2024)
8.1.2 Middle East & Africa Genetic Engineering Drug Revenue by Country (2019-2024)
8.2 Middle East & Africa Genetic Engineering Drug Sales by Type
8.3 Middle East & Africa Genetic Engineering Drug Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Genetic Engineering Drug
10.3 Manufacturing Process Analysis of Genetic Engineering Drug
10.4 Industry Chain Structure of Genetic Engineering Drug
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Genetic Engineering Drug Distributors
11.3 Genetic Engineering Drug Customer
12 WORLD FORECAST REVIEW FOR GENETIC ENGINEERING DRUG BY GEOGRAPHIC REGION
12.1 Global Genetic Engineering Drug Market Size Forecast by Region
12.1.1 Global Genetic Engineering Drug Forecast by Region (2025-2030)
12.1.2 Global Genetic Engineering Drug Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Genetic Engineering Drug Forecast by Type
12.7 Global Genetic Engineering Drug Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Shanghai Lansheng Guojian Pharmaceutical
13.1.1 Shanghai Lansheng Guojian Pharmaceutical Company Information
13.1.2 Shanghai Lansheng Guojian Pharmaceutical Genetic Engineering Drug Product Portfolios and Specifications
13.1.3 Shanghai Lansheng Guojian Pharmaceutical Genetic Engineering Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Shanghai Lansheng Guojian Pharmaceutical Main Business Overview
13.1.5 Shanghai Lansheng Guojian Pharmaceutical Latest Developments
13.2 Biotech Pharmaceutical
13.2.1 Biotech Pharmaceutical Company Information
13.2.2 Biotech Pharmaceutical Genetic Engineering Drug Product Portfolios and Specifications
13.2.3 Biotech Pharmaceutical Genetic Engineering Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Biotech Pharmaceutical Main Business Overview
13.2.5 Biotech Pharmaceutical Latest Developments
13.3 Anhui Anke Biotechnology
13.3.1 Anhui Anke Biotechnology Company Information
13.3.2 Anhui Anke Biotechnology Genetic Engineering Drug Product Portfolios and Specifications
13.3.3 Anhui Anke Biotechnology Genetic Engineering Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Anhui Anke Biotechnology Main Business Overview
13.3.5 Anhui Anke Biotechnology Latest Developments
13.4 GeneScience Pharmaceuticals
13.4.1 GeneScience Pharmaceuticals Company Information
13.4.2 GeneScience Pharmaceuticals Genetic Engineering Drug Product Portfolios and Specifications
13.4.3 GeneScience Pharmaceuticals Genetic Engineering Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 GeneScience Pharmaceuticals Main Business Overview
13.4.5 GeneScience Pharmaceuticals Latest Developments
13.5 Beijing SL Pharmaceutical
13.5.1 Beijing SL Pharmaceutical Company Information
13.5.2 Beijing SL Pharmaceutical Genetic Engineering Drug Product Portfolios and Specifications
13.5.3 Beijing SL Pharmaceutical Genetic Engineering Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Beijing SL Pharmaceutical Main Business Overview
13.5.5 Beijing SL Pharmaceutical Latest Developments
13.6 Jiangsu Sihuan Bioengineering
13.6.1 Jiangsu Sihuan Bioengineering Company Information
13.6.2 Jiangsu Sihuan Bioengineering Genetic Engineering Drug Product Portfolios and Specifications
13.6.3 Jiangsu Sihuan Bioengineering Genetic Engineering Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 Jiangsu Sihuan Bioengineering Main Business Overview
13.6.5 Jiangsu Sihuan Bioengineering Latest Developments
13.7 Shenzhen Neptunus Interlong Bio-Technique
13.7.1 Shenzhen Neptunus Interlong Bio-Technique Company Information
13.7.2 Shenzhen Neptunus Interlong Bio-Technique Genetic Engineering Drug Product Portfolios and Specifications
13.7.3 Shenzhen Neptunus Interlong Bio-Technique Genetic Engineering Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 Shenzhen Neptunus Interlong Bio-Technique Main Business Overview
13.7.5 Shenzhen Neptunus Interlong Bio-Technique Latest Developments
13.8 3SBio
13.8.1 3SBio Company Information
13.8.2 3SBio Genetic Engineering Drug Product Portfolios and Specifications
13.8.3 3SBio Genetic Engineering Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 3SBio Main Business Overview
13.8.5 3SBio Latest Developments
13.9 Tonghua Dongbao Pharmaceutical
13.9.1 Tonghua Dongbao Pharmaceutical Company Information
13.9.2 Tonghua Dongbao Pharmaceutical Genetic Engineering Drug Product Portfolios and Specifications
13.9.3 Tonghua Dongbao Pharmaceutical Genetic Engineering Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.9.4 Tonghua Dongbao Pharmaceutical Main Business Overview
13.9.5 Tonghua Dongbao Pharmaceutical Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Genetic Engineering Drug Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Genetic Engineering Drug by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Genetic Engineering Drug by Country/Region, 2019, 2023 & 2030
2.2 Genetic Engineering Drug Segment by Type
2.2.1 Monoclonal Antibody
2.2.2 Recombinant Human Erythropoietin
2.2.3 Recombinant Human Interferon
2.2.4 Recombinant Human Growth Hormone
2.2.5 Recombinant Human Insulin
2.3 Genetic Engineering Drug Sales by Type
2.3.1 Global Genetic Engineering Drug Sales Market Share by Type (2019-2024)
2.3.2 Global Genetic Engineering Drug Revenue and Market Share by Type (2019-2024)
2.3.3 Global Genetic Engineering Drug Sale Price by Type (2019-2024)
2.4 Genetic Engineering Drug Segment by Application
2.4.1 Medicine
2.4.2 Research
2.4.3 Industrial
2.4.4 Agriculture
2.4.5 Other
2.5 Genetic Engineering Drug Sales by Application
2.5.1 Global Genetic Engineering Drug Sale Market Share by Application (2019-2024)
2.5.2 Global Genetic Engineering Drug Revenue and Market Share by Application (2019-2024)
2.5.3 Global Genetic Engineering Drug Sale Price by Application (2019-2024)
3 GLOBAL GENETIC ENGINEERING DRUG BY COMPANY
3.1 Global Genetic Engineering Drug Breakdown Data by Company
3.1.1 Global Genetic Engineering Drug Annual Sales by Company (2019-2024)
3.1.2 Global Genetic Engineering Drug Sales Market Share by Company (2019-2024)
3.2 Global Genetic Engineering Drug Annual Revenue by Company (2019-2024)
3.2.1 Global Genetic Engineering Drug Revenue by Company (2019-2024)
3.2.2 Global Genetic Engineering Drug Revenue Market Share by Company (2019-2024)
3.3 Global Genetic Engineering Drug Sale Price by Company
3.4 Key Manufacturers Genetic Engineering Drug Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Genetic Engineering Drug Product Location Distribution
3.4.2 Players Genetic Engineering Drug Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR GENETIC ENGINEERING DRUG BY GEOGRAPHIC REGION
4.1 World Historic Genetic Engineering Drug Market Size by Geographic Region (2019-2024)
4.1.1 Global Genetic Engineering Drug Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Genetic Engineering Drug Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Genetic Engineering Drug Market Size by Country/Region (2019-2024)
4.2.1 Global Genetic Engineering Drug Annual Sales by Country/Region (2019-2024)
4.2.2 Global Genetic Engineering Drug Annual Revenue by Country/Region (2019-2024)
4.3 Americas Genetic Engineering Drug Sales Growth
4.4 APAC Genetic Engineering Drug Sales Growth
4.5 Europe Genetic Engineering Drug Sales Growth
4.6 Middle East & Africa Genetic Engineering Drug Sales Growth
5 AMERICAS
5.1 Americas Genetic Engineering Drug Sales by Country
5.1.1 Americas Genetic Engineering Drug Sales by Country (2019-2024)
5.1.2 Americas Genetic Engineering Drug Revenue by Country (2019-2024)
5.2 Americas Genetic Engineering Drug Sales by Type
5.3 Americas Genetic Engineering Drug Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Genetic Engineering Drug Sales by Region
6.1.1 APAC Genetic Engineering Drug Sales by Region (2019-2024)
6.1.2 APAC Genetic Engineering Drug Revenue by Region (2019-2024)
6.2 APAC Genetic Engineering Drug Sales by Type
6.3 APAC Genetic Engineering Drug Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Genetic Engineering Drug by Country
7.1.1 Europe Genetic Engineering Drug Sales by Country (2019-2024)
7.1.2 Europe Genetic Engineering Drug Revenue by Country (2019-2024)
7.2 Europe Genetic Engineering Drug Sales by Type
7.3 Europe Genetic Engineering Drug Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Genetic Engineering Drug by Country
8.1.1 Middle East & Africa Genetic Engineering Drug Sales by Country (2019-2024)
8.1.2 Middle East & Africa Genetic Engineering Drug Revenue by Country (2019-2024)
8.2 Middle East & Africa Genetic Engineering Drug Sales by Type
8.3 Middle East & Africa Genetic Engineering Drug Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Genetic Engineering Drug
10.3 Manufacturing Process Analysis of Genetic Engineering Drug
10.4 Industry Chain Structure of Genetic Engineering Drug
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Genetic Engineering Drug Distributors
11.3 Genetic Engineering Drug Customer
12 WORLD FORECAST REVIEW FOR GENETIC ENGINEERING DRUG BY GEOGRAPHIC REGION
12.1 Global Genetic Engineering Drug Market Size Forecast by Region
12.1.1 Global Genetic Engineering Drug Forecast by Region (2025-2030)
12.1.2 Global Genetic Engineering Drug Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Genetic Engineering Drug Forecast by Type
12.7 Global Genetic Engineering Drug Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Shanghai Lansheng Guojian Pharmaceutical
13.1.1 Shanghai Lansheng Guojian Pharmaceutical Company Information
13.1.2 Shanghai Lansheng Guojian Pharmaceutical Genetic Engineering Drug Product Portfolios and Specifications
13.1.3 Shanghai Lansheng Guojian Pharmaceutical Genetic Engineering Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Shanghai Lansheng Guojian Pharmaceutical Main Business Overview
13.1.5 Shanghai Lansheng Guojian Pharmaceutical Latest Developments
13.2 Biotech Pharmaceutical
13.2.1 Biotech Pharmaceutical Company Information
13.2.2 Biotech Pharmaceutical Genetic Engineering Drug Product Portfolios and Specifications
13.2.3 Biotech Pharmaceutical Genetic Engineering Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Biotech Pharmaceutical Main Business Overview
13.2.5 Biotech Pharmaceutical Latest Developments
13.3 Anhui Anke Biotechnology
13.3.1 Anhui Anke Biotechnology Company Information
13.3.2 Anhui Anke Biotechnology Genetic Engineering Drug Product Portfolios and Specifications
13.3.3 Anhui Anke Biotechnology Genetic Engineering Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Anhui Anke Biotechnology Main Business Overview
13.3.5 Anhui Anke Biotechnology Latest Developments
13.4 GeneScience Pharmaceuticals
13.4.1 GeneScience Pharmaceuticals Company Information
13.4.2 GeneScience Pharmaceuticals Genetic Engineering Drug Product Portfolios and Specifications
13.4.3 GeneScience Pharmaceuticals Genetic Engineering Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 GeneScience Pharmaceuticals Main Business Overview
13.4.5 GeneScience Pharmaceuticals Latest Developments
13.5 Beijing SL Pharmaceutical
13.5.1 Beijing SL Pharmaceutical Company Information
13.5.2 Beijing SL Pharmaceutical Genetic Engineering Drug Product Portfolios and Specifications
13.5.3 Beijing SL Pharmaceutical Genetic Engineering Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Beijing SL Pharmaceutical Main Business Overview
13.5.5 Beijing SL Pharmaceutical Latest Developments
13.6 Jiangsu Sihuan Bioengineering
13.6.1 Jiangsu Sihuan Bioengineering Company Information
13.6.2 Jiangsu Sihuan Bioengineering Genetic Engineering Drug Product Portfolios and Specifications
13.6.3 Jiangsu Sihuan Bioengineering Genetic Engineering Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 Jiangsu Sihuan Bioengineering Main Business Overview
13.6.5 Jiangsu Sihuan Bioengineering Latest Developments
13.7 Shenzhen Neptunus Interlong Bio-Technique
13.7.1 Shenzhen Neptunus Interlong Bio-Technique Company Information
13.7.2 Shenzhen Neptunus Interlong Bio-Technique Genetic Engineering Drug Product Portfolios and Specifications
13.7.3 Shenzhen Neptunus Interlong Bio-Technique Genetic Engineering Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 Shenzhen Neptunus Interlong Bio-Technique Main Business Overview
13.7.5 Shenzhen Neptunus Interlong Bio-Technique Latest Developments
13.8 3SBio
13.8.1 3SBio Company Information
13.8.2 3SBio Genetic Engineering Drug Product Portfolios and Specifications
13.8.3 3SBio Genetic Engineering Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 3SBio Main Business Overview
13.8.5 3SBio Latest Developments
13.9 Tonghua Dongbao Pharmaceutical
13.9.1 Tonghua Dongbao Pharmaceutical Company Information
13.9.2 Tonghua Dongbao Pharmaceutical Genetic Engineering Drug Product Portfolios and Specifications
13.9.3 Tonghua Dongbao Pharmaceutical Genetic Engineering Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.9.4 Tonghua Dongbao Pharmaceutical Main Business Overview
13.9.5 Tonghua Dongbao Pharmaceutical Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Genetic Engineering Drug Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Genetic Engineering Drug Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Monoclonal Antibody
Table 4. Major Players of Recombinant Human Erythropoietin
Table 5. Major Players of Recombinant Human Interferon
Table 6. Major Players of Recombinant Human Growth Hormone
Table 7. Major Players of Recombinant Human Insulin
Table 8. Global Genetic Engineering Drug Sales by Type (2019-2024) & (K Units)
Table 9. Global Genetic Engineering Drug Sales Market Share by Type (2019-2024)
Table 10. Global Genetic Engineering Drug Revenue by Type (2019-2024) & ($ million)
Table 11. Global Genetic Engineering Drug Revenue Market Share by Type (2019-2024)
Table 12. Global Genetic Engineering Drug Sale Price by Type (2019-2024) & (USD/Unit)
Table 13. Global Genetic Engineering Drug Sales by Application (2019-2024) & (K Units)
Table 14. Global Genetic Engineering Drug Sales Market Share by Application (2019-2024)
Table 15. Global Genetic Engineering Drug Revenue by Application (2019-2024)
Table 16. Global Genetic Engineering Drug Revenue Market Share by Application (2019-2024)
Table 17. Global Genetic Engineering Drug Sale Price by Application (2019-2024) & (USD/Unit)
Table 18. Global Genetic Engineering Drug Sales by Company (2019-2024) & (K Units)
Table 19. Global Genetic Engineering Drug Sales Market Share by Company (2019-2024)
Table 20. Global Genetic Engineering Drug Revenue by Company (2019-2024) ($ Millions)
Table 21. Global Genetic Engineering Drug Revenue Market Share by Company (2019-2024)
Table 22. Global Genetic Engineering Drug Sale Price by Company (2019-2024) & (USD/Unit)
Table 23. Key Manufacturers Genetic Engineering Drug Producing Area Distribution and Sales Area
Table 24. Players Genetic Engineering Drug Products Offered
Table 25. Genetic Engineering Drug Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 26. New Products and Potential Entrants
Table 27. Mergers & Acquisitions, Expansion
Table 28. Global Genetic Engineering Drug Sales by Geographic Region (2019-2024) & (K Units)
Table 29. Global Genetic Engineering Drug Sales Market Share Geographic Region (2019-2024)
Table 30. Global Genetic Engineering Drug Revenue by Geographic Region (2019-2024) & ($ millions)
Table 31. Global Genetic Engineering Drug Revenue Market Share by Geographic Region (2019-2024)
Table 32. Global Genetic Engineering Drug Sales by Country/Region (2019-2024) & (K Units)
Table 33. Global Genetic Engineering Drug Sales Market Share by Country/Region (2019-2024)
Table 34. Global Genetic Engineering Drug Revenue by Country/Region (2019-2024) & ($ millions)
Table 35. Global Genetic Engineering Drug Revenue Market Share by Country/Region (2019-2024)
Table 36. Americas Genetic Engineering Drug Sales by Country (2019-2024) & (K Units)
Table 37. Americas Genetic Engineering Drug Sales Market Share by Country (2019-2024)
Table 38. Americas Genetic Engineering Drug Revenue by Country (2019-2024) & ($ Millions)
Table 39. Americas Genetic Engineering Drug Revenue Market Share by Country (2019-2024)
Table 40. Americas Genetic Engineering Drug Sales by Type (2019-2024) & (K Units)
Table 41. Americas Genetic Engineering Drug Sales by Application (2019-2024) & (K Units)
Table 42. APAC Genetic Engineering Drug Sales by Region (2019-2024) & (K Units)
Table 43. APAC Genetic Engineering Drug Sales Market Share by Region (2019-2024)
Table 44. APAC Genetic Engineering Drug Revenue by Region (2019-2024) & ($ Millions)
Table 45. APAC Genetic Engineering Drug Revenue Market Share by Region (2019-2024)
Table 46. APAC Genetic Engineering Drug Sales by Type (2019-2024) & (K Units)
Table 47. APAC Genetic Engineering Drug Sales by Application (2019-2024) & (K Units)
Table 48. Europe Genetic Engineering Drug Sales by Country (2019-2024) & (K Units)
Table 49. Europe Genetic Engineering Drug Sales Market Share by Country (2019-2024)
Table 50. Europe Genetic Engineering Drug Revenue by Country (2019-2024) & ($ Millions)
Table 51. Europe Genetic Engineering Drug Revenue Market Share by Country (2019-2024)
Table 52. Europe Genetic Engineering Drug Sales by Type (2019-2024) & (K Units)
Table 53. Europe Genetic Engineering Drug Sales by Application (2019-2024) & (K Units)
Table 54. Middle East & Africa Genetic Engineering Drug Sales by Country (2019-2024) & (K Units)
Table 55. Middle East & Africa Genetic Engineering Drug Sales Market Share by Country (2019-2024)
Table 56. Middle East & Africa Genetic Engineering Drug Revenue by Country (2019-2024) & ($ Millions)
Table 57. Middle East & Africa Genetic Engineering Drug Revenue Market Share by Country (2019-2024)
Table 58. Middle East & Africa Genetic Engineering Drug Sales by Type (2019-2024) & (K Units)
Table 59. Middle East & Africa Genetic Engineering Drug Sales by Application (2019-2024) & (K Units)
Table 60. Key Market Drivers & Growth Opportunities of Genetic Engineering Drug
Table 61. Key Market Challenges & Risks of Genetic Engineering Drug
Table 62. Key Industry Trends of Genetic Engineering Drug
Table 63. Genetic Engineering Drug Raw Material
Table 64. Key Suppliers of Raw Materials
Table 65. Genetic Engineering Drug Distributors List
Table 66. Genetic Engineering Drug Customer List
Table 67. Global Genetic Engineering Drug Sales Forecast by Region (2025-2030) & (K Units)
Table 68. Global Genetic Engineering Drug Revenue Forecast by Region (2025-2030) & ($ millions)
Table 69. Americas Genetic Engineering Drug Sales Forecast by Country (2025-2030) & (K Units)
Table 70. Americas Genetic Engineering Drug Revenue Forecast by Country (2025-2030) & ($ millions)
Table 71. APAC Genetic Engineering Drug Sales Forecast by Region (2025-2030) & (K Units)
Table 72. APAC Genetic Engineering Drug Revenue Forecast by Region (2025-2030) & ($ millions)
Table 73. Europe Genetic Engineering Drug Sales Forecast by Country (2025-2030) & (K Units)
Table 74. Europe Genetic Engineering Drug Revenue Forecast by Country (2025-2030) & ($ millions)
Table 75. Middle East & Africa Genetic Engineering Drug Sales Forecast by Country (2025-2030) & (K Units)
Table 76. Middle East & Africa Genetic Engineering Drug Revenue Forecast by Country (2025-2030) & ($ millions)
Table 77. Global Genetic Engineering Drug Sales Forecast by Type (2025-2030) & (K Units)
Table 78. Global Genetic Engineering Drug Revenue Forecast by Type (2025-2030) & ($ Millions)
Table 79. Global Genetic Engineering Drug Sales Forecast by Application (2025-2030) & (K Units)
Table 80. Global Genetic Engineering Drug Revenue Forecast by Application (2025-2030) & ($ Millions)
Table 81. Shanghai Lansheng Guojian Pharmaceutical Basic Information, Genetic Engineering Drug Manufacturing Base, Sales Area and Its Competitors
Table 82. Shanghai Lansheng Guojian Pharmaceutical Genetic Engineering Drug Product Portfolios and Specifications
Table 83. Shanghai Lansheng Guojian Pharmaceutical Genetic Engineering Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 84. Shanghai Lansheng Guojian Pharmaceutical Main Business
Table 85. Shanghai Lansheng Guojian Pharmaceutical Latest Developments
Table 86. Biotech Pharmaceutical Basic Information, Genetic Engineering Drug Manufacturing Base, Sales Area and Its Competitors
Table 87. Biotech Pharmaceutical Genetic Engineering Drug Product Portfolios and Specifications
Table 88. Biotech Pharmaceutical Genetic Engineering Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 89. Biotech Pharmaceutical Main Business
Table 90. Biotech Pharmaceutical Latest Developments
Table 91. Anhui Anke Biotechnology Basic Information, Genetic Engineering Drug Manufacturing Base, Sales Area and Its Competitors
Table 92. Anhui Anke Biotechnology Genetic Engineering Drug Product Portfolios and Specifications
Table 93. Anhui Anke Biotechnology Genetic Engineering Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 94. Anhui Anke Biotechnology Main Business
Table 95. Anhui Anke Biotechnology Latest Developments
Table 96. GeneScience Pharmaceuticals Basic Information, Genetic Engineering Drug Manufacturing Base, Sales Area and Its Competitors
Table 97. GeneScience Pharmaceuticals Genetic Engineering Drug Product Portfolios and Specifications
Table 98. GeneScience Pharmaceuticals Genetic Engineering Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 99. GeneScience Pharmaceuticals Main Business
Table 100. GeneScience Pharmaceuticals Latest Developments
Table 101. Beijing SL Pharmaceutical Basic Information, Genetic Engineering Drug Manufacturing Base, Sales Area and Its Competitors
Table 102. Beijing SL Pharmaceutical Genetic Engineering Drug Product Portfolios and Specifications
Table 103. Beijing SL Pharmaceutical Genetic Engineering Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 104. Beijing SL Pharmaceutical Main Business
Table 105. Beijing SL Pharmaceutical Latest Developments
Table 106. Jiangsu Sihuan Bioengineering Basic Information, Genetic Engineering Drug Manufacturing Base, Sales Area and Its Competitors
Table 107. Jiangsu Sihuan Bioengineering Genetic Engineering Drug Product Portfolios and Specifications
Table 108. Jiangsu Sihuan Bioengineering Genetic Engineering Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 109. Jiangsu Sihuan Bioengineering Main Business
Table 110. Jiangsu Sihuan Bioengineering Latest Developments
Table 111. Shenzhen Neptunus Interlong Bio-Technique Basic Information, Genetic Engineering Drug Manufacturing Base, Sales Area and Its Competitors
Table 112. Shenzhen Neptunus Interlong Bio-Technique Genetic Engineering Drug Product Portfolios and Specifications
Table 113. Shenzhen Neptunus Interlong Bio-Technique Genetic Engineering Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 114. Shenzhen Neptunus Interlong Bio-Technique Main Business
Table 115. Shenzhen Neptunus Interlong Bio-Technique Latest Developments
Table 116. 3SBio Basic Information, Genetic Engineering Drug Manufacturing Base, Sales Area and Its Competitors
Table 117. 3SBio Genetic Engineering Drug Product Portfolios and Specifications
Table 118. 3SBio Genetic Engineering Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 119. 3SBio Main Business
Table 120. 3SBio Latest Developments
Table 121. Tonghua Dongbao Pharmaceutical Basic Information, Genetic Engineering Drug Manufacturing Base, Sales Area and Its Competitors
Table 122. Tonghua Dongbao Pharmaceutical Genetic Engineering Drug Product Portfolios and Specifications
Table 123. Tonghua Dongbao Pharmaceutical Genetic Engineering Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 124. Tonghua Dongbao Pharmaceutical Main Business
Table 125. Tonghua Dongbao Pharmaceutical Latest Developments
Table 1. Genetic Engineering Drug Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Genetic Engineering Drug Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Monoclonal Antibody
Table 4. Major Players of Recombinant Human Erythropoietin
Table 5. Major Players of Recombinant Human Interferon
Table 6. Major Players of Recombinant Human Growth Hormone
Table 7. Major Players of Recombinant Human Insulin
Table 8. Global Genetic Engineering Drug Sales by Type (2019-2024) & (K Units)
Table 9. Global Genetic Engineering Drug Sales Market Share by Type (2019-2024)
Table 10. Global Genetic Engineering Drug Revenue by Type (2019-2024) & ($ million)
Table 11. Global Genetic Engineering Drug Revenue Market Share by Type (2019-2024)
Table 12. Global Genetic Engineering Drug Sale Price by Type (2019-2024) & (USD/Unit)
Table 13. Global Genetic Engineering Drug Sales by Application (2019-2024) & (K Units)
Table 14. Global Genetic Engineering Drug Sales Market Share by Application (2019-2024)
Table 15. Global Genetic Engineering Drug Revenue by Application (2019-2024)
Table 16. Global Genetic Engineering Drug Revenue Market Share by Application (2019-2024)
Table 17. Global Genetic Engineering Drug Sale Price by Application (2019-2024) & (USD/Unit)
Table 18. Global Genetic Engineering Drug Sales by Company (2019-2024) & (K Units)
Table 19. Global Genetic Engineering Drug Sales Market Share by Company (2019-2024)
Table 20. Global Genetic Engineering Drug Revenue by Company (2019-2024) ($ Millions)
Table 21. Global Genetic Engineering Drug Revenue Market Share by Company (2019-2024)
Table 22. Global Genetic Engineering Drug Sale Price by Company (2019-2024) & (USD/Unit)
Table 23. Key Manufacturers Genetic Engineering Drug Producing Area Distribution and Sales Area
Table 24. Players Genetic Engineering Drug Products Offered
Table 25. Genetic Engineering Drug Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 26. New Products and Potential Entrants
Table 27. Mergers & Acquisitions, Expansion
Table 28. Global Genetic Engineering Drug Sales by Geographic Region (2019-2024) & (K Units)
Table 29. Global Genetic Engineering Drug Sales Market Share Geographic Region (2019-2024)
Table 30. Global Genetic Engineering Drug Revenue by Geographic Region (2019-2024) & ($ millions)
Table 31. Global Genetic Engineering Drug Revenue Market Share by Geographic Region (2019-2024)
Table 32. Global Genetic Engineering Drug Sales by Country/Region (2019-2024) & (K Units)
Table 33. Global Genetic Engineering Drug Sales Market Share by Country/Region (2019-2024)
Table 34. Global Genetic Engineering Drug Revenue by Country/Region (2019-2024) & ($ millions)
Table 35. Global Genetic Engineering Drug Revenue Market Share by Country/Region (2019-2024)
Table 36. Americas Genetic Engineering Drug Sales by Country (2019-2024) & (K Units)
Table 37. Americas Genetic Engineering Drug Sales Market Share by Country (2019-2024)
Table 38. Americas Genetic Engineering Drug Revenue by Country (2019-2024) & ($ Millions)
Table 39. Americas Genetic Engineering Drug Revenue Market Share by Country (2019-2024)
Table 40. Americas Genetic Engineering Drug Sales by Type (2019-2024) & (K Units)
Table 41. Americas Genetic Engineering Drug Sales by Application (2019-2024) & (K Units)
Table 42. APAC Genetic Engineering Drug Sales by Region (2019-2024) & (K Units)
Table 43. APAC Genetic Engineering Drug Sales Market Share by Region (2019-2024)
Table 44. APAC Genetic Engineering Drug Revenue by Region (2019-2024) & ($ Millions)
Table 45. APAC Genetic Engineering Drug Revenue Market Share by Region (2019-2024)
Table 46. APAC Genetic Engineering Drug Sales by Type (2019-2024) & (K Units)
Table 47. APAC Genetic Engineering Drug Sales by Application (2019-2024) & (K Units)
Table 48. Europe Genetic Engineering Drug Sales by Country (2019-2024) & (K Units)
Table 49. Europe Genetic Engineering Drug Sales Market Share by Country (2019-2024)
Table 50. Europe Genetic Engineering Drug Revenue by Country (2019-2024) & ($ Millions)
Table 51. Europe Genetic Engineering Drug Revenue Market Share by Country (2019-2024)
Table 52. Europe Genetic Engineering Drug Sales by Type (2019-2024) & (K Units)
Table 53. Europe Genetic Engineering Drug Sales by Application (2019-2024) & (K Units)
Table 54. Middle East & Africa Genetic Engineering Drug Sales by Country (2019-2024) & (K Units)
Table 55. Middle East & Africa Genetic Engineering Drug Sales Market Share by Country (2019-2024)
Table 56. Middle East & Africa Genetic Engineering Drug Revenue by Country (2019-2024) & ($ Millions)
Table 57. Middle East & Africa Genetic Engineering Drug Revenue Market Share by Country (2019-2024)
Table 58. Middle East & Africa Genetic Engineering Drug Sales by Type (2019-2024) & (K Units)
Table 59. Middle East & Africa Genetic Engineering Drug Sales by Application (2019-2024) & (K Units)
Table 60. Key Market Drivers & Growth Opportunities of Genetic Engineering Drug
Table 61. Key Market Challenges & Risks of Genetic Engineering Drug
Table 62. Key Industry Trends of Genetic Engineering Drug
Table 63. Genetic Engineering Drug Raw Material
Table 64. Key Suppliers of Raw Materials
Table 65. Genetic Engineering Drug Distributors List
Table 66. Genetic Engineering Drug Customer List
Table 67. Global Genetic Engineering Drug Sales Forecast by Region (2025-2030) & (K Units)
Table 68. Global Genetic Engineering Drug Revenue Forecast by Region (2025-2030) & ($ millions)
Table 69. Americas Genetic Engineering Drug Sales Forecast by Country (2025-2030) & (K Units)
Table 70. Americas Genetic Engineering Drug Revenue Forecast by Country (2025-2030) & ($ millions)
Table 71. APAC Genetic Engineering Drug Sales Forecast by Region (2025-2030) & (K Units)
Table 72. APAC Genetic Engineering Drug Revenue Forecast by Region (2025-2030) & ($ millions)
Table 73. Europe Genetic Engineering Drug Sales Forecast by Country (2025-2030) & (K Units)
Table 74. Europe Genetic Engineering Drug Revenue Forecast by Country (2025-2030) & ($ millions)
Table 75. Middle East & Africa Genetic Engineering Drug Sales Forecast by Country (2025-2030) & (K Units)
Table 76. Middle East & Africa Genetic Engineering Drug Revenue Forecast by Country (2025-2030) & ($ millions)
Table 77. Global Genetic Engineering Drug Sales Forecast by Type (2025-2030) & (K Units)
Table 78. Global Genetic Engineering Drug Revenue Forecast by Type (2025-2030) & ($ Millions)
Table 79. Global Genetic Engineering Drug Sales Forecast by Application (2025-2030) & (K Units)
Table 80. Global Genetic Engineering Drug Revenue Forecast by Application (2025-2030) & ($ Millions)
Table 81. Shanghai Lansheng Guojian Pharmaceutical Basic Information, Genetic Engineering Drug Manufacturing Base, Sales Area and Its Competitors
Table 82. Shanghai Lansheng Guojian Pharmaceutical Genetic Engineering Drug Product Portfolios and Specifications
Table 83. Shanghai Lansheng Guojian Pharmaceutical Genetic Engineering Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 84. Shanghai Lansheng Guojian Pharmaceutical Main Business
Table 85. Shanghai Lansheng Guojian Pharmaceutical Latest Developments
Table 86. Biotech Pharmaceutical Basic Information, Genetic Engineering Drug Manufacturing Base, Sales Area and Its Competitors
Table 87. Biotech Pharmaceutical Genetic Engineering Drug Product Portfolios and Specifications
Table 88. Biotech Pharmaceutical Genetic Engineering Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 89. Biotech Pharmaceutical Main Business
Table 90. Biotech Pharmaceutical Latest Developments
Table 91. Anhui Anke Biotechnology Basic Information, Genetic Engineering Drug Manufacturing Base, Sales Area and Its Competitors
Table 92. Anhui Anke Biotechnology Genetic Engineering Drug Product Portfolios and Specifications
Table 93. Anhui Anke Biotechnology Genetic Engineering Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 94. Anhui Anke Biotechnology Main Business
Table 95. Anhui Anke Biotechnology Latest Developments
Table 96. GeneScience Pharmaceuticals Basic Information, Genetic Engineering Drug Manufacturing Base, Sales Area and Its Competitors
Table 97. GeneScience Pharmaceuticals Genetic Engineering Drug Product Portfolios and Specifications
Table 98. GeneScience Pharmaceuticals Genetic Engineering Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 99. GeneScience Pharmaceuticals Main Business
Table 100. GeneScience Pharmaceuticals Latest Developments
Table 101. Beijing SL Pharmaceutical Basic Information, Genetic Engineering Drug Manufacturing Base, Sales Area and Its Competitors
Table 102. Beijing SL Pharmaceutical Genetic Engineering Drug Product Portfolios and Specifications
Table 103. Beijing SL Pharmaceutical Genetic Engineering Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 104. Beijing SL Pharmaceutical Main Business
Table 105. Beijing SL Pharmaceutical Latest Developments
Table 106. Jiangsu Sihuan Bioengineering Basic Information, Genetic Engineering Drug Manufacturing Base, Sales Area and Its Competitors
Table 107. Jiangsu Sihuan Bioengineering Genetic Engineering Drug Product Portfolios and Specifications
Table 108. Jiangsu Sihuan Bioengineering Genetic Engineering Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 109. Jiangsu Sihuan Bioengineering Main Business
Table 110. Jiangsu Sihuan Bioengineering Latest Developments
Table 111. Shenzhen Neptunus Interlong Bio-Technique Basic Information, Genetic Engineering Drug Manufacturing Base, Sales Area and Its Competitors
Table 112. Shenzhen Neptunus Interlong Bio-Technique Genetic Engineering Drug Product Portfolios and Specifications
Table 113. Shenzhen Neptunus Interlong Bio-Technique Genetic Engineering Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 114. Shenzhen Neptunus Interlong Bio-Technique Main Business
Table 115. Shenzhen Neptunus Interlong Bio-Technique Latest Developments
Table 116. 3SBio Basic Information, Genetic Engineering Drug Manufacturing Base, Sales Area and Its Competitors
Table 117. 3SBio Genetic Engineering Drug Product Portfolios and Specifications
Table 118. 3SBio Genetic Engineering Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 119. 3SBio Main Business
Table 120. 3SBio Latest Developments
Table 121. Tonghua Dongbao Pharmaceutical Basic Information, Genetic Engineering Drug Manufacturing Base, Sales Area and Its Competitors
Table 122. Tonghua Dongbao Pharmaceutical Genetic Engineering Drug Product Portfolios and Specifications
Table 123. Tonghua Dongbao Pharmaceutical Genetic Engineering Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 124. Tonghua Dongbao Pharmaceutical Main Business
Table 125. Tonghua Dongbao Pharmaceutical Latest Developments
LIST OF FIGURES
Figure 1. Picture of Genetic Engineering Drug
Figure 2. Genetic Engineering Drug Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Genetic Engineering Drug Sales Growth Rate 2019-2030 (K Units)
Figure 7. Global Genetic Engineering Drug Revenue Growth Rate 2019-2030 ($ Millions)
Figure 8. Genetic Engineering Drug Sales by Region (2019, 2023 & 2030) & ($ Millions)
Figure 9. Product Picture of Monoclonal Antibody
Figure 10. Product Picture of Recombinant Human Erythropoietin
Figure 11. Product Picture of Recombinant Human Interferon
Figure 12. Product Picture of Recombinant Human Growth Hormone
Figure 13. Product Picture of Recombinant Human Insulin
Figure 14. Global Genetic Engineering Drug Sales Market Share by Type in 2023
Figure 15. Global Genetic Engineering Drug Revenue Market Share by Type (2019-2024)
Figure 16. Genetic Engineering Drug Consumed in Medicine
Figure 17. Global Genetic Engineering Drug Market: Medicine (2019-2024) & (K Units)
Figure 18. Genetic Engineering Drug Consumed in Research
Figure 19. Global Genetic Engineering Drug Market: Research (2019-2024) & (K Units)
Figure 20. Genetic Engineering Drug Consumed in Industrial
Figure 21. Global Genetic Engineering Drug Market: Industrial (2019-2024) & (K Units)
Figure 22. Genetic Engineering Drug Consumed in Agriculture
Figure 23. Global Genetic Engineering Drug Market: Agriculture (2019-2024) & (K Units)
Figure 24. Genetic Engineering Drug Consumed in Other
Figure 25. Global Genetic Engineering Drug Market: Other (2019-2024) & (K Units)
Figure 26. Global Genetic Engineering Drug Sales Market Share by Application (2023)
Figure 27. Global Genetic Engineering Drug Revenue Market Share by Application in 2023
Figure 28. Genetic Engineering Drug Sales Market by Company in 2023 (K Units)
Figure 29. Global Genetic Engineering Drug Sales Market Share by Company in 2023
Figure 30. Genetic Engineering Drug Revenue Market by Company in 2023 ($ Million)
Figure 31. Global Genetic Engineering Drug Revenue Market Share by Company in 2023
Figure 32. Global Genetic Engineering Drug Sales Market Share by Geographic Region (2019-2024)
Figure 33. Global Genetic Engineering Drug Revenue Market Share by Geographic Region in 2023
Figure 34. Americas Genetic Engineering Drug Sales 2019-2024 (K Units)
Figure 35. Americas Genetic Engineering Drug Revenue 2019-2024 ($ Millions)
Figure 36. APAC Genetic Engineering Drug Sales 2019-2024 (K Units)
Figure 37. APAC Genetic Engineering Drug Revenue 2019-2024 ($ Millions)
Figure 38. Europe Genetic Engineering Drug Sales 2019-2024 (K Units)
Figure 39. Europe Genetic Engineering Drug Revenue 2019-2024 ($ Millions)
Figure 40. Middle East & Africa Genetic Engineering Drug Sales 2019-2024 (K Units)
Figure 41. Middle East & Africa Genetic Engineering Drug Revenue 2019-2024 ($ Millions)
Figure 42. Americas Genetic Engineering Drug Sales Market Share by Country in 2023
Figure 43. Americas Genetic Engineering Drug Revenue Market Share by Country in 2023
Figure 44. Americas Genetic Engineering Drug Sales Market Share by Type (2019-2024)
Figure 45. Americas Genetic Engineering Drug Sales Market Share by Application (2019-2024)
Figure 46. United States Genetic Engineering Drug Revenue Growth 2019-2024 ($ Millions)
Figure 47. Canada Genetic Engineering Drug Revenue Growth 2019-2024 ($ Millions)
Figure 48. Mexico Genetic Engineering Drug Revenue Growth 2019-2024 ($ Millions)
Figure 49. Brazil Genetic Engineering Drug Revenue Growth 2019-2024 ($ Millions)
Figure 50. APAC Genetic Engineering Drug Sales Market Share by Region in 2023
Figure 51. APAC Genetic Engineering Drug Revenue Market Share by Regions in 2023
Figure 52. APAC Genetic Engineering Drug Sales Market Share by Type (2019-2024)
Figure 53. APAC Genetic Engineering Drug Sales Market Share by Application (2019-2024)
Figure 54. China Genetic Engineering Drug Revenue Growth 2019-2024 ($ Millions)
Figure 55. Japan Genetic Engineering Drug Revenue Growth 2019-2024 ($ Millions)
Figure 56. South Korea Genetic Engineering Drug Revenue Growth 2019-2024 ($ Millions)
Figure 57. Southeast Asia Genetic Engineering Drug Revenue Growth 2019-2024 ($ Millions)
Figure 58. India Genetic Engineering Drug Revenue Growth 2019-2024 ($ Millions)
Figure 59. Australia Genetic Engineering Drug Revenue Growth 2019-2024 ($ Millions)
Figure 60. China Taiwan Genetic Engineering Drug Revenue Growth 2019-2024 ($ Millions)
Figure 61. Europe Genetic Engineering Drug Sales Market Share by Country in 2023
Figure 62. Europe Genetic Engineering Drug Revenue Market Share by Country in 2023
Figure 63. Europe Genetic Engineering Drug Sales Market Share by Type (2019-2024)
Figure 64. Europe Genetic Engineering Drug Sales Market Share by Application (2019-2024)
Figure 65. Germany Genetic Engineering Drug Revenue Growth 2019-2024 ($ Millions)
Figure 66. France Genetic Engineering Drug Revenue Growth 2019-2024 ($ Millions)
Figure 67. UK Genetic Engineering Drug Revenue Growth 2019-2024 ($ Millions)
Figure 68. Italy Genetic Engineering Drug Revenue Growth 2019-2024 ($ Millions)
Figure 69. Russia Genetic Engineering Drug Revenue Growth 2019-2024 ($ Millions)
Figure 70. Middle East & Africa Genetic Engineering Drug Sales Market Share by Country in 2023
Figure 71. Middle East & Africa Genetic Engineering Drug Revenue Market Share by Country in 2023
Figure 72. Middle East & Africa Genetic Engineering Drug Sales Market Share by Type (2019-2024)
Figure 73. Middle East & Africa Genetic Engineering Drug Sales Market Share by Application (2019-2024)
Figure 74. Egypt Genetic Engineering Drug Revenue Growth 2019-2024 ($ Millions)
Figure 75. South Africa Genetic Engineering Drug Revenue Growth 2019-2024 ($ Millions)
Figure 76. Israel Genetic Engineering Drug Revenue Growth 2019-2024 ($ Millions)
Figure 77. Turkey Genetic Engineering Drug Revenue Growth 2019-2024 ($ Millions)
Figure 78. GCC Country Genetic Engineering Drug Revenue Growth 2019-2024 ($ Millions)
Figure 79. Manufacturing Cost Structure Analysis of Genetic Engineering Drug in 2023
Figure 80. Manufacturing Process Analysis of Genetic Engineering Drug
Figure 81. Industry Chain Structure of Genetic Engineering Drug
Figure 82. Channels of Distribution
Figure 83. Global Genetic Engineering Drug Sales Market Forecast by Region (2025-2030)
Figure 84. Global Genetic Engineering Drug Revenue Market Share Forecast by Region (2025-2030)
Figure 85. Global Genetic Engineering Drug Sales Market Share Forecast by Type (2025-2030)
Figure 86. Global Genetic Engineering Drug Revenue Market Share Forecast by Type (2025-2030)
Figure 87. Global Genetic Engineering Drug Sales Market Share Forecast by Application (2025-2030)
Figure 88. Global Genetic Engineering Drug Revenue Market Share Forecast by Application (2025-2030)
Figure 1. Picture of Genetic Engineering Drug
Figure 2. Genetic Engineering Drug Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Genetic Engineering Drug Sales Growth Rate 2019-2030 (K Units)
Figure 7. Global Genetic Engineering Drug Revenue Growth Rate 2019-2030 ($ Millions)
Figure 8. Genetic Engineering Drug Sales by Region (2019, 2023 & 2030) & ($ Millions)
Figure 9. Product Picture of Monoclonal Antibody
Figure 10. Product Picture of Recombinant Human Erythropoietin
Figure 11. Product Picture of Recombinant Human Interferon
Figure 12. Product Picture of Recombinant Human Growth Hormone
Figure 13. Product Picture of Recombinant Human Insulin
Figure 14. Global Genetic Engineering Drug Sales Market Share by Type in 2023
Figure 15. Global Genetic Engineering Drug Revenue Market Share by Type (2019-2024)
Figure 16. Genetic Engineering Drug Consumed in Medicine
Figure 17. Global Genetic Engineering Drug Market: Medicine (2019-2024) & (K Units)
Figure 18. Genetic Engineering Drug Consumed in Research
Figure 19. Global Genetic Engineering Drug Market: Research (2019-2024) & (K Units)
Figure 20. Genetic Engineering Drug Consumed in Industrial
Figure 21. Global Genetic Engineering Drug Market: Industrial (2019-2024) & (K Units)
Figure 22. Genetic Engineering Drug Consumed in Agriculture
Figure 23. Global Genetic Engineering Drug Market: Agriculture (2019-2024) & (K Units)
Figure 24. Genetic Engineering Drug Consumed in Other
Figure 25. Global Genetic Engineering Drug Market: Other (2019-2024) & (K Units)
Figure 26. Global Genetic Engineering Drug Sales Market Share by Application (2023)
Figure 27. Global Genetic Engineering Drug Revenue Market Share by Application in 2023
Figure 28. Genetic Engineering Drug Sales Market by Company in 2023 (K Units)
Figure 29. Global Genetic Engineering Drug Sales Market Share by Company in 2023
Figure 30. Genetic Engineering Drug Revenue Market by Company in 2023 ($ Million)
Figure 31. Global Genetic Engineering Drug Revenue Market Share by Company in 2023
Figure 32. Global Genetic Engineering Drug Sales Market Share by Geographic Region (2019-2024)
Figure 33. Global Genetic Engineering Drug Revenue Market Share by Geographic Region in 2023
Figure 34. Americas Genetic Engineering Drug Sales 2019-2024 (K Units)
Figure 35. Americas Genetic Engineering Drug Revenue 2019-2024 ($ Millions)
Figure 36. APAC Genetic Engineering Drug Sales 2019-2024 (K Units)
Figure 37. APAC Genetic Engineering Drug Revenue 2019-2024 ($ Millions)
Figure 38. Europe Genetic Engineering Drug Sales 2019-2024 (K Units)
Figure 39. Europe Genetic Engineering Drug Revenue 2019-2024 ($ Millions)
Figure 40. Middle East & Africa Genetic Engineering Drug Sales 2019-2024 (K Units)
Figure 41. Middle East & Africa Genetic Engineering Drug Revenue 2019-2024 ($ Millions)
Figure 42. Americas Genetic Engineering Drug Sales Market Share by Country in 2023
Figure 43. Americas Genetic Engineering Drug Revenue Market Share by Country in 2023
Figure 44. Americas Genetic Engineering Drug Sales Market Share by Type (2019-2024)
Figure 45. Americas Genetic Engineering Drug Sales Market Share by Application (2019-2024)
Figure 46. United States Genetic Engineering Drug Revenue Growth 2019-2024 ($ Millions)
Figure 47. Canada Genetic Engineering Drug Revenue Growth 2019-2024 ($ Millions)
Figure 48. Mexico Genetic Engineering Drug Revenue Growth 2019-2024 ($ Millions)
Figure 49. Brazil Genetic Engineering Drug Revenue Growth 2019-2024 ($ Millions)
Figure 50. APAC Genetic Engineering Drug Sales Market Share by Region in 2023
Figure 51. APAC Genetic Engineering Drug Revenue Market Share by Regions in 2023
Figure 52. APAC Genetic Engineering Drug Sales Market Share by Type (2019-2024)
Figure 53. APAC Genetic Engineering Drug Sales Market Share by Application (2019-2024)
Figure 54. China Genetic Engineering Drug Revenue Growth 2019-2024 ($ Millions)
Figure 55. Japan Genetic Engineering Drug Revenue Growth 2019-2024 ($ Millions)
Figure 56. South Korea Genetic Engineering Drug Revenue Growth 2019-2024 ($ Millions)
Figure 57. Southeast Asia Genetic Engineering Drug Revenue Growth 2019-2024 ($ Millions)
Figure 58. India Genetic Engineering Drug Revenue Growth 2019-2024 ($ Millions)
Figure 59. Australia Genetic Engineering Drug Revenue Growth 2019-2024 ($ Millions)
Figure 60. China Taiwan Genetic Engineering Drug Revenue Growth 2019-2024 ($ Millions)
Figure 61. Europe Genetic Engineering Drug Sales Market Share by Country in 2023
Figure 62. Europe Genetic Engineering Drug Revenue Market Share by Country in 2023
Figure 63. Europe Genetic Engineering Drug Sales Market Share by Type (2019-2024)
Figure 64. Europe Genetic Engineering Drug Sales Market Share by Application (2019-2024)
Figure 65. Germany Genetic Engineering Drug Revenue Growth 2019-2024 ($ Millions)
Figure 66. France Genetic Engineering Drug Revenue Growth 2019-2024 ($ Millions)
Figure 67. UK Genetic Engineering Drug Revenue Growth 2019-2024 ($ Millions)
Figure 68. Italy Genetic Engineering Drug Revenue Growth 2019-2024 ($ Millions)
Figure 69. Russia Genetic Engineering Drug Revenue Growth 2019-2024 ($ Millions)
Figure 70. Middle East & Africa Genetic Engineering Drug Sales Market Share by Country in 2023
Figure 71. Middle East & Africa Genetic Engineering Drug Revenue Market Share by Country in 2023
Figure 72. Middle East & Africa Genetic Engineering Drug Sales Market Share by Type (2019-2024)
Figure 73. Middle East & Africa Genetic Engineering Drug Sales Market Share by Application (2019-2024)
Figure 74. Egypt Genetic Engineering Drug Revenue Growth 2019-2024 ($ Millions)
Figure 75. South Africa Genetic Engineering Drug Revenue Growth 2019-2024 ($ Millions)
Figure 76. Israel Genetic Engineering Drug Revenue Growth 2019-2024 ($ Millions)
Figure 77. Turkey Genetic Engineering Drug Revenue Growth 2019-2024 ($ Millions)
Figure 78. GCC Country Genetic Engineering Drug Revenue Growth 2019-2024 ($ Millions)
Figure 79. Manufacturing Cost Structure Analysis of Genetic Engineering Drug in 2023
Figure 80. Manufacturing Process Analysis of Genetic Engineering Drug
Figure 81. Industry Chain Structure of Genetic Engineering Drug
Figure 82. Channels of Distribution
Figure 83. Global Genetic Engineering Drug Sales Market Forecast by Region (2025-2030)
Figure 84. Global Genetic Engineering Drug Revenue Market Share Forecast by Region (2025-2030)
Figure 85. Global Genetic Engineering Drug Sales Market Share Forecast by Type (2025-2030)
Figure 86. Global Genetic Engineering Drug Revenue Market Share Forecast by Type (2025-2030)
Figure 87. Global Genetic Engineering Drug Sales Market Share Forecast by Application (2025-2030)
Figure 88. Global Genetic Engineering Drug Revenue Market Share Forecast by Application (2025-2030)
